Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population
Recruiting · NCT06634121 · Interventional (participants receive a specific treatment) · Lead sponsor: LMU Klinikum
View the official record on ClinicalTrials.gov →Interventions studied
Transcatheter mitral valve edge-to-edge repair (M-TEER)
What this trial is about
To investigate potential differences in procedural outcomes of both commercially available transcatheter edge-to-edge mitral valve repair devices in a non-selected clinical setting.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age equal or above 18 years
- Written consent
- Heart Team recommends M-TEER
Exclusion criteria
- Mitral Stenosis (MV mean PG \> 5 mmHg)
- Cardiogenic shock or hemodynamic instability at the time of intervention
- Active endocarditis
- Participant in another interventional cardiology study
Where it is running
1 location listed.
- LMU Klinikum - Munich, Bavaria, Germany